Scalp blocks with levobupivacaine reduced postoperative pain and the requirement of anti-hypertensive agent after craniotomy for aneurysmal clipping

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000274

Enrollment

Registered

2011-11-21

Start date

2011-10-13

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : In control group, scalp nerve block is performed with saline (7 ml), and in Levobupiva group, scalp nerve block is performed with 0.75% levobupivacaine (7 ml) before the patient is awakened a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for elective cerebral aneurysmal clipping under general anesthesia are included.

Exclusion criteria

Exclusion criteria: The exclusion criteria included inability to understand or incapacity to use the visual analog scale (VAS), proven or suspected allergy to local anesthetics, past history of craniotomy, and chronic(more than 2 wk) treatment with narcotic medications.

Design outcomes

Primary

Measure	Time frame
the requirement of antihypertensive agent ;Pain score (NRS score);Consumption of fentanyl (patient-controlled analgesia, PCA consumption)	—

Secondary

Measure	Time frame
arterial pressure, heart rate;the time interval between the patient recovery and the administration of the first dose of PCA and first use of rescue analgesics;The use of vasopressor (dopamine);the presence of nausea and vomiting;the presence of respiratory depression;the use of rescue analgesics;the discontinuation of patient-controlled analgesia machine	—

Countries

Korea, Republic of

Contacts

Public ContactJinyoung Hwang

Seoul National University Bundang Hospital

Outcome results